Rallybio Corporation is a biotechnology company focused on discovering and developing innovative therapies for rare and life-threatening diseases

The company specializes in creating breakthrough treatments that target the underlying causes of these conditions, aiming to significantly improve patient outcomes. Rallybio's research and development efforts are centered around advancing its robust pipeline of candidates designed to address critical unmet medical needs within the rare disease community. Through strategic partnerships and a commitment to scientific excellence, Rallybio is positioned to make a meaningful impact on patients' lives.